期刊文献+

RANKL诱导破骨细胞前体细胞分化成熟 被引量:4

RANKL inducing osteoclast differentiation and maturity in RAW264.7 cells
下载PDF
导出
摘要 目的用核因子-KB受体活化因子配体(RANKL)诱导破骨细胞前体细胞分化成熟,建立获取成熟破骨细胞的方法。方法用破骨细胞前体细胞RAW264.7细胞为模型,RANKL诱导培养4~9d,抗酒石酸酸性磷酸酶(TRAP)染色观察TRAP阳性多核细胞形成,罗丹明-鬼笔环肽荧光染色观察纤维性肌动蛋白(F-actin)环,DAPI染色观察细胞核,甲苯胺蓝染色观察牛骨片表面的吸收陷窝情况。结果RANKL可诱导RAW264.7细胞形成TRAP染色阳性的多核细胞,形成F-actin环,骨片吸收陷窝明显。结论RANKL可诱导RAW264.7细胞向成熟破骨细胞分化,该诱导模型可用于破骨细胞分化研究。 Objective To explore the method of getting mature osteoclasts by RANKL inducing osteoclast differentiation and maturity in RAW264. 7 cells. Methods RAW264. 7 cells were treated with RANKL for 4 or 9 days, TRAP-positive multinuclear cells were examined by TRAP staining and F-actin rings were observed by fluorescent microscope with rhodamine-Phalloidin. Osteoclastic absorption function was determined by bone resorption pits formation on calf cortex slice with toluidine blue staining. Results RAW264. 7 cells could be were induced to be TRAP-positive multinuclear cells, and to form F-aetin rings. Resorption pits made by ceils treated with RANKL were more than that of without RANKL significantly. Conclusions RANKL could induce osteoclast differentiation and maturity in RAW264. 7 cells. And it could be used as a models for research of osteoelast differentiation research.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第6期963-965,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金资助项目(No.81000785)
关键词 RAW264.7细胞 RANKL 破骨细胞 细胞分化 RAW264. 7 RANKL Osteoelast Cell differentiation
  • 相关文献

参考文献12

  • 1Ishii M, Saeki Y. Osteoclast cell fusion : mechanisms and molecules [J]. Mod Rheumatol,2008 ; 18 ( 3 ) :220-7.
  • 2Kong YY,Yoshida H, Sarosi l,et al. OPGL is a key regulator of osteoclastogenesis,lymphocyte development and lymph-node organogenesis [J]. Nature, 1999 ; 397 ( 6717 ) : 315-23.
  • 3Teitelbaum SL. Bone resorption by osteoclasts [J]. Science (Washington D C) ,2000 ;289 ( 5484 ) : 1504-8.
  • 4Rodan GA, Martin TJ. Therapeutic approaches to bone diseazes [J]. Science ,2000 ;289(5484 ) : 1508-14.
  • 5Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation [J]. Bone ,2007 ;40 ( 2 ) :251-64.
  • 6Boyle W J, Simonet WS, Lacey DL. Osteoclast differentiation and activation[J]. Nature ,2003 ;423 ( 6937 ) :337-42.
  • 7Orlandini SZ, Formigli L, Benvenuti S,et al. Functional and structural interactions between osteoblastic and preosteoclastic cells in vitro[J].Cell Tissue Res,1995 ;281 ( 1 ) :33-42.
  • 8Loomer PM, Ellen RP, Tenenbaum HC. Osteogenic and osteoclastic cell interaction : development of a coculture system [J]. Cell Tissue Res, 1998 ;294( 1 ) :99-108.
  • 9Kieslinger M, Folberth S, Dobreva G, et al. EBF2 regulates osteoblast-dependent differentiation of osteoclasts [J]. Dev C ell, 2005 ; 9 ( 6 ) : 757 -67.
  • 10Battaglino R,Kim D,Fu J,et al. c-myc is required for osteoclast differentiation [J]. J Bone Mineral Res, 2002 ; 17 ( 5 ) : 763-73.

同被引文献34

  • 1张晓晓,刘胜,薛晓红.具有雌激素类似作用的中药研究进展[J].中西医结合学报,2005,3(2):149-153. 被引量:49
  • 2Kawatani M, Okumura H, Honda K, et al. The identilication oi an os- teoclastogenesis inhibitor through the inhibition of glyoxalase I. Proc Natl Acad Sci U S A ,2008,105 : 11691-11696.
  • 3Yee AJ,Raje NS. Denosumab,a RANK ligand inhibitor,for the man- agement of bone loss in cancer patients. Clin Interv Aging,2012,7: 331-338.
  • 4Kajiya H, Okamoto F, Nemoto T, et al. RANKL-induced TRPV2 ex- pression regulates osteoclastogenesis via calcium oscillations. Cell Cal- cium,2010,48:260-269.
  • 5Ernest N J, Logsdon N J, McFerrin MB, et al. Biophysical properties of human medullobIastoma cells. J Membr Bio1,2010 ,237 :59-69.
  • 6Kim D, Cavanaugh EJ, Kim I, et al. Heteromeric TASK-I/TASK-3 is the major oxygen-sensitive background K + channel in rat carotid body glomus cells. J Physiol,2009,587:2963-2975.
  • 7Kato K, Morita I. Acidosis environment promotes osteoclast formation by acting on the last phase of preosteoclast differentiation:a study to elucidate the action points of acidosis and search for putative target molecules. Eur J Pharmaco1,2011,663 :27-39.
  • 8Hu W, Yang X, Zhe C, et al. Puerarin inhibits iNl_lS, COX-2 and CRP expression via suppression of NF-kappaB activation in LPS-induced RAW264. 7 macrophage cells. Pharmacol Rep ,2011,63:781-789.
  • 9Humphrey MB, Daws MR, Spusta SC, et al. TREM2, a DAP12-associ- ated receptor, regulates osteoclast differentiation and function. J Bone Miner Res,2006,21:237-245.
  • 10Moreno JL, Kaczmarek M, Keegan AD, et al. IL4 suppresses osteo- clast development and mature osteoclast function by a STAT6-depend- ent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood ,2003,102 : 1078-1086.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部